CD274 and neoplasm: Meanwhile, powerful antitumor immunity can also be generated, resulting in durable tumor regression.[201, 202] Therefore, predicting patient response to treatment, monitoring the process of complex immune cells in the microenvironment of living tumors, and evaluating heterogeneous changes in PD‐L1 within tumors are vital for improving the function of immune checkpoint blockade.